Changes are happening - please bear with us while we update our site.

Changes are happening - please bear with us while we update our site. Click here to give us your advice and feedback.

Why this top fund manager holds Afterpay (ASX:APT) and Xero (ASX:XRO) shares

Top performing fund manager, Hyperion Asset Management, recently released an update on their Hyperion Australian Growth Companies Fund.

Top-performing fund manager, Hyperion Asset Management, recently released an update on its Hyperion Australian Growth Companies Fund.

The fund has achieved an annualised return since inception (30 September 2002) of 12.3%, versus a return of 8.6% by its benchmark, the S&P/ASX 300 (INDEXASX: XKO). The dramatic effect of compounding returns over time can be appreciated on the below chart.

Source: Hyperion

Hyperion believes that “the highest proven quality businesses with the strongest competitive advantages and organic growth opportunities produce superior shareholder returns over the long-term. Long term capital preservation is paramount”.

Hyperion’s top five holdings 

Hyperion recently disclosed the top five holdings for its Australian Growth Companies Fund.

As at 31 August, the fund’s largest holdings were in WiseTech Global Ltd (ASX: WTC), Fisher & Paykel Healthcare Corp Ltd (ASX: FPH), Xero Limited (ASX: XRO), Afterpay Ltd (ASX: APT) and CSL Limited (ASX: CSL).

Source: Hyperion Australian Growth Companies Fund August 2020

Why does Hyperion hold these shares?

Over time, Hyperion has provided some hints as to why it holds these companies in its portfolio.

Hyperion hosted a webinar in May this year titled ‘Winners in a modern world’. Deputy Chief Investor Jason Orthman said, WiseTech and Xero, they’re not anymore obvious because there’s no blueprint, there’s no databases for these businesses. They are really the next blue chips and they’re disrupting the incumbents”.

Following this, Hyperion published an update in June this year titled ‘Companies that will benefit in the post COVID-19 world’.

“Within the Australian market, we particularly like healthcare and technology stocks, and the Hyperion Australian Growth Companies Fund has a significant international tilt with many of the businesses, including CSL, ResMed and Xero, having diversified and global revenue streams with large addressable markets”.

Meanwhile, explaining its reasoning for adding Fisher & Paykel to its portfolio in 2017, Hyperion said: “FPH-AU is a high quality business with strong balance sheet and long track record of generating high returns on capital. It has strong free cash flow, a robust growth trajectory and long management tenure”.

As for Afterpay, in July this year, Chief Investor Officer Mark Arnold told The Australian newspaper, “there is a switch from credit cards to buy-now-pay-later which led us to consider Afterpay and it’s one of the reasons why we’re not involved with the major banks both here and globally”.

If you’re interested in investing for growth, check out Rask Media’s ASX growth shares page for the latest news, analysis and share ideas.

$50,000 per year in passive income from shares? Yes, please!

With interest rates UP, now could be one of the best times to start earning passive income from a portfolio. Imagine earning 4%, 5% — or more — in dividend passive income from the best shares, LICs, or ETFs… it’s like magic.

So how do the best investors do it?

Chief Investment Officer Owen Rask has just released his brand new passive income report. Owen has outlined 10 of his favourite ETFs and shares to watch, his rules for passive income investing, why he would buy ETFs before LICs and more.

You can INSTANTLY access Owen’s report for FREE by CLICKING HERE NOW and creating a 100% FREE Rask Account.

(Psst. By creating a free Rask account, you’ll also get access to 15+ online courses, 1,000+ podcasts, invites to events, a weekly value investing newsletter and more!)

Unsubscribe anytime. Read our TermsFinancial Services GuidePrivacy Policy. We’ll never sell your email address. Our company is Australian owned.

Information warning: The information on this website is published by The Rask Group Pty Ltd (ABN: 36 622 810 995) is limited to factual information or (at most) general financial advice only. That means, the information and advice does not take into account your objectives, financial situation or needs. It is not specific to you, your needs, goals or objectives. Because of that, you should consider if the advice is appropriate to you and your needs, before acting on the information. If you don’t know what your needs are, you should consult a trusted and licensed financial adviser who can provide you with personal financial product advice. In addition, you should obtain and read the product disclosure statement (PDS) before making a decision to acquire a financial product. Please read our Terms and Conditions and Financial Services Guide before using this website. The Rask Group Pty Ltd is a Corporate Authorised Representative (#1280930) of AFSL #383169.

At the time of publishing, the author of this article does not have a financial or commercial interest in any of the companies mentioned
Skip to content